30.86
-0.27 (-0.87%)
-0.27 (-0.87%)
Upgrade to Real-Time
Regular Market
Low
24.671
High
54.2081
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.27 | -0.87% | 30.86 | 11:02:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 31.27 | 30.79 | 31.65 | 31.13 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 30.85 | 30.89 | 0.04 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,495 | 253,867 | $ 31.24 | $ 7,930,476 | 1,405,457 | 24.671 - 54.2081 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:03:20 | 8 | $ 30.8756 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 4.52B | 146.69M | 136.82M | $ - | $ - | -1.59 | -24.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 33.23 | 33.40 | 29.14 | 30.63 | 1,978,098 | -2.37 | -7.13% |
| 1 Month | 30.25 | 33.99 | 27.75 | 30.67 | 2,457,750 | 0.61 | 2.02% |
| 3 Months | 44.01 | 53.04 | 27.75 | 34.30 | 1,920,547 | -13.15 | -29.88% |
| 6 Months | 37.16 | 54.2081 | 27.75 | 38.61 | 1,525,884 | -6.30 | -16.95% |
| 1 Year | 37.94 | 54.2081 | 24.671 | 34.95 | 1,599,279 | -7.08 | -18.66% |
| 3 Years | 14.85 | 54.2081 | 7.26 | 24.59 | 1,458,388 | 16.01 | 107.81% |
| 5 Years | 6.00 | 54.2081 | 4.45 | 22.14 | 1,062,182 | 24.86 | 414.33% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. |
